Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Wednesday, May 17 2023
08:25 AM – 08:50 AM PT

In vitro pharmacology study of gene therapy using retina organoids of CLN2 patient-derived induced pluripotent stem cells

Kwi Hye Kim, PhD. REGENXBIO Inc, Rockville, MD

Disclosures: K. Kim: None.

© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.